Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
Clinical trial NCT06320353 · COMPLETED
Trial details
- NCT number
- NCT06320353
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2024-08-07
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.